Lung Cancer Europe
Many Faces, One Voice
Lung Cancer Europe brings together national lung cancer organisations from across Europe. We work to improve diagnosis, treatment, care and support for everyone affected by lung cancer, and to make sure the community is heard where decisions are made at European level.
This is our home for advocacy, projects and priorities, alongside the latest news, policy developments and research from across the lung cancer community.
equity across borders
•
real world data
•
no more delays
•
clear communication
•
access matters
•
quality of life
•
equity across borders • real world data • no more delays • clear communication • access matters • quality of life •
News
A news feed covering lung cancer in Europe, including policy, research, screening, treatment developments and updates from Lung Cancer Europe and our member organisations.
News from our member organisations
Lung Cancer Europe member organisations can submit news from their own work and from their national or local lung cancer landscape.
This may include research developments, policy changes, screening updates, access issues, campaigns, reports or events relevant to lung cancer in your country.
All submissions are reviewed by Lung Cancer Europe. We may edit for clarity and length. Submission does not guarantee publication.
You can also browse updates from across our network, including member news, webinars, surveys and developments relevant to the lung cancer community.
FAQs
Who is Lung Cancer Europe News for?
1
Lung Cancer Europe News is for patient organisations, advocates, policymakers, healthcare professionals, researchers and anyone working to improve lung cancer outcomes across Europe.
Lung Cancer News provides updates on early detection and screening, access to diagnosis and biomarker testing, treatment advances, clinical research, prevention policy, health system reform and lived experience perspectives.
2
What topics do you cover?
Do you report on lung cancer treatment advances?
3
Yes. We share updates on new therapies, clinical trial developments and policy decisions that affect access to innovation across Europe.
Do you cover lung cancer screening in Europe?
4
Yes. Screening and early detection are central to improving lung cancer outcomes. We will follow developments in implementation, policy and equity across European countries.
Our Charter
for lung cancer in Europe
Our Charter sets out what people affected by lung cancer should be able to expect across Europe between 2026–2030. It reflects a shared commitment to better diagnosis, care, information and support.